Managing diabetes in patients with diabetes of long duration.
Diabetes Educ · 2012
Last updated 2026-05-28Older adults make up a large portion of people with type 2 diabetes, and treatment plans should be tailored to their health, life expectancy, and diabetes-related risks. For those with long-term diabetes, especially those with kidney problems, avoiding severe low blood sugar is a key concern. Recent findings suggest that GLP-1 drugs, when combined with insulin, may help improve blood sugar control, reduce insulin doses, and lower the risk of low blood sugar while also potentially aiding weight loss.
AI summary of the abstract below.
| Journal | Diabetes Educ, 2012 |
|---|---|
| Citations | 3 |
| Relative citation ratio | 0.10 |
| NIH percentile | 7 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
PURPOSE: The purpose of this article is to review clinical issues related to the management of hyperglycemia in older patients with diabetes of long duration.
CONCLUSION: Older adults represent an extensive proportion of patients with type 2 diabetes. Treatment goals need to be individualized to take into account comorbid conditions, life expectancy, diabetes complications, and the benefits of glycemic control. For both older patients and especially those with chronic renal insufficiency, the most important drug-related adverse effect to avoid is hypoglycemia, and avoidance of any severe hypoglycemia should be paramount. Patients with long duration of diabetes are often treated with insulin. Recent data show that glucagon-like peptide-1 receptor agonists may be used in combination with insulin for patients not achieving glycemic goals, with reductions in the doses of insulin used and with a low risk of hypoglycemia and possible weight loss.
Verbatim abstract via PubMed 22661393 ↗